Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
What Drives Upper Extremity Disability in Early Rheumatoid Arthritis?
November 2024
Upper extremity disability in rheumatoid arthritis fluctuates over time, with pain and hand function playing a critical role, study finds.
Read more
29 Oct 2021
Treatment Tapering and Withdrawal in People with Rheumatoid Arthritis in Stable Remission
The Rheumatoid Arthritis in Ongoing Remission (RETRO) study aimed to determine outcomes following tapering and withdrawal…
29 Oct 2021
COVID-19 Vaccination in People with Multiple Sclerosis
Consequently, for interferon-β, teriflunomide, and dimethyl fumarate, COVID-19 vaccination is “likely to be effective…”
2 Aug 2021
Treating Ankylosing Spondylitis Using Engineered JAK Inhibitor: Upadacitinib
Researchers explored the efficacy of upadacitinib in treating AS. Upadacitinib targets the inflammatory pathway and works by inhibiting JAK, reducing the ability of JAK to cause inflammation in the joints.
2 Aug 2021
Effective Novel Drug for Axial Psoriatic Arthritis
Phase III clinical trials analysed the efficaPhase III clinical trials analysed the efficacy of a novel antibody, guselkumab, for psoriatic arthritis with axial symptoms.
6 May 2021
A Prescription of Aerobic Exercise for Rheumatic Disorders
EXERCISE reduces the risk of cardiovascular disease in those with rheumatic disorders. Individuals with autoimmune rheumatic diseases (ARDs), such as rheumatoid arthritis and lupus, are more likely to develop atherosclerosis and are thereby at a higher risk of a heart attack and other cardiovascular disorders.
6 May 2021
A Safer Strategy for Steroid Use in Patients with Lupus
LUPUS could now be treated with a lower dose of steroids, lessening the side effects experienced by patients and improving their health long-term. The research was published by Eric Morand and the Rheumatology Group at Monash University, Melbourne, Australia, who aimed to gain insight into ways of tracking patient exposure to steroids.
5 Feb 2021
Could Colchicine Cut COVID-19 Hospital Admissions and Deaths?
COLCHICINE, an anti-inflammatory oral drug commonly used for the treatment of gout and rheumatic diseases, has reportedly been shown to significantly…
5 Feb 2021
Osteopontin and Lung Scarring in Scleroderma
OSTEOPONTIN (OPN), a protein known to function as an immune system modulator and play a role in tissue regeneration, may be responsible for driving lung…
Loading posts...
« Previous
1
…
7
8
9
10
11
…
20
Next »